Correlation Between ETC On and Mereo BioPharma

Can any of the company-specific risk be diversified away by investing in both ETC On and Mereo BioPharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ETC On and Mereo BioPharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ETC on CMCI and Mereo BioPharma Group, you can compare the effects of market volatilities on ETC On and Mereo BioPharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ETC On with a short position of Mereo BioPharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of ETC On and Mereo BioPharma.

Diversification Opportunities for ETC On and Mereo BioPharma

-0.21

Correlation Coefficient

ETC On  Mereo BioPharma

Very good diversification

The 3 months correlation between ETC and Mereo is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding ETC on CMCI and Mereo BioPharma Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mereo BioPharma Group and ETC On is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ETC on CMCI are associated (or correlated) with Mereo BioPharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mereo BioPharma Group has no effect on the direction of ETC On i.e., ETC On and Mereo BioPharma go up and down completely randomly.

Pair Corralation between ETC On and Mereo BioPharma

Assuming the 90 days trading horizon ETC on CMCI is expected to generate 0.22 times more return on investment than Mereo BioPharma. However, ETC on CMCI is 4.55 times less risky than Mereo BioPharma. It trades about 0.05 of its potential returns per unit of risk. Mereo BioPharma Group is currently generating about -0.14 per unit of risk. If you would invest  17,541  in ETC on CMCI on December 30, 2024 and sell it today you would earn a total of  414.00  from holding ETC on CMCI or generate 2.36% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.46%
Values	Daily Returns

ETC on CMCI  vs.  Mereo BioPharma Group

ETC on CMCI

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in ETC on CMCI are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, ETC On is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Mereo BioPharma Group

Risk-Adjusted Performance

Very Weak

Over the last 90 days Mereo BioPharma Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with ETC On and Mereo BioPharma

The main advantage of trading using opposite ETC On and Mereo BioPharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ETC On position performs unexpectedly, Mereo BioPharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mereo BioPharma will offset losses from the drop in Mereo BioPharma's long position.

The idea behind ETC on CMCI and Mereo BioPharma Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.